Assignee
OTTAWA HEART INST RES CORP
CA·14 granted patents·6 pending applications·113 citations·filing 2000–2024
Top patents by PatentIndex Score
20 records- 0189US6514523B1Carrier particles for drug delivery and process for preparationOTTAWA HEART INST RES CORP·Filed 2000·Granted Feb 4, 2003·58 cites·28 claims
- 0286US7813841B2Rubidium elution system controlOTTAWA HEART INST RES CORP·Filed 2006·Granted Oct 12, 2010·27 cites·17 claims
- 0386US6828306B2Charged lipid compositions and methods for their useOTTAWA HEART INST RES CORP·Filed 2001·Granted Dec 7, 2004·19 cites·12 claims
- 0480US12390578B2Infusion procedure for enhancing image qualityOTTAWA HEART INST RES CORP·Filed 2024·Granted Aug 19, 2025·0 cites·20 claims
- 0577US6960472B2Monoclonal antibodies against N-Terminus proBNPOTTAWA HEART INST RES CORP·Filed 2003·Granted Nov 1, 2005·9 cites·4 claims
- 0675US11986622B2Infusion procedure for enhancing image qualityOTTAWA HEART INST RES CORP·Filed 2023·Granted May 21, 2024·0 cites·21 claims
- 0764US8343915B2Use of heat-shock protein 27 for cardiovascular disease prevention and treatmentOTTAWA HEART INST RES CORP·Filed 2008·Granted Jan 1, 2013·0 cites·10 claims
- 0862US11648343B2Infusion procedure for enhancing image qualityOTTAWA HEART INST RES CORP·Filed 2019·Granted May 16, 2023·0 cites·24 claims
- 0957US7390783B2Charged phospholipid compositions and methods for their useOTTAWA HEART INST RES CORP·Filed 2004·Granted Jun 24, 2008·0 cites·19 claims
- 1057US2009117090A1Inhibition of glycogen synthase kinase 3 beta in arterial repair and stent re-endothelializationOTTAWA HEART INST RES CORP·Filed 2008·Application pending·0 cites
- 1156US2023380777A1Improved dosing method for positron emission tomography imagingOTTAWA HEART INST RES CORP·Filed 2023·Application pending·0 cites
- 1251US10865412B2Therapeutics targeting IGFBP7 for the treatment or prevention of heart failure and metabolic diseasesOTTAWA HEART INST RES CORP·Filed 2017·Granted Dec 15, 2020·0 cites·17 claims
- 1349US8343916B2Use of heat-shock protein 27 for cardiovascular disease prevention and treatmentOTTAWA HEART INST RES CORP·Filed 2010·Granted Jan 1, 2013·0 cites·14 claims
- 1446US2024186017A1Systems, Methods and Apparatus for Predicting Hemodynamic EventsOTTAWA HEART INST RES CORP·Filed 2024·Application pending·0 cites
- 1545US11795434B2Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereofOTTAWA HEART INST RES CORP·Filed 2019·Granted Oct 24, 2023·0 cites·19 claims
- 1643US2023146521A1Health care resources managementOTTAWA HEART INST RES CORP·Filed 2021·Application pending·0 cites
- 1740US11497832B2Biocompatible hydrogel compositions and uses thereofOTTAWA HEART INST RES CORP·Filed 2018·Granted Nov 15, 2022·0 cites·21 claims
- 1840US2020147118A1Compositions and methods for detection, risk assessment and treatment of diabetes, obesity, and inflammationOTTAWA HEART INST RES CORP·Filed 2018·Application pending·0 cites
- 1934US11083756B2Serum-free and xenogen-free human cardiac explant-derived stem cells and uses and methods for the production thereofOTTAWA HEART INST RES CORP·Filed 2017·Granted Aug 10, 2021·0 cites·21 claims
- 2027US2016324992A1Identification and treatment of vulnerable plaquesOTTAWA HEART INST RES CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OTTAWA HEART INST RES CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →